Alpharadin radium-223: Phase I/IIa ongoing

Algeta disclosed in its 3Q12 earnings that it and partner Bayer began the Phase IIa portion of the open-label, international Phase I/IIa BC1-10 trial evaluating docetaxel with and without Alpharadin. ...